Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 2: UGT2B15
![metabolism overview](https://genomind.com/wp-content/uploads/2022/03/Metabolism-Overview_300dpi-1030x580.png)
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.
Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 1: CYP450
![pk gene overview](https://genomind.com/wp-content/uploads/2022/03/PK-Gene-Overview_300dpi-1030x580.png)
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.